» Articles » PMID: 12514112

Intravascular Tissue Factor Initiates Coagulation Via Circulating Microvesicles and Platelets

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2003 Jan 7
PMID 12514112
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Although tissue factor (TF), the principial initiator of physiological coagulation and pathological thrombosis, has recently been proposed to be present in human blood, the functional significance and location of the intravascular TF is unknown. In the plasma portion of blood, we found TF to be mainly associated with circulating microvesicles. By cell sorting with the specific marker CD42b, platelet-derived microvesicles were identified as a major location of the plasma TF. This was confirmed by the presence of full-length TF in microvesicles acutely shedded from the activated platelets. TF was observed to be stored in the alpha-granules and the open canalicular system of resting platelets and to be exposed on the cell surface after platelet activation. Functional competence of the blood-based TF was enabled when the microvesicles and platelets adhered to neutrophils, as mediated by P-selectin and neutrophil counterreceptor (PSGL-1, CD18 integrins) interactions. Moreover, neutrophil-secreted oxygen radical species supported the intravascular TF activity. The pools of platelet and microvesicle TF contributed additively and to a comparable extent to the overall blood TF activity, indicating a substantial participation of the microvesicle TF. Our results introduce a new concept of TF-mediated coagulation crucially dependent on TF associated with microvesicles and activated platelets, which principally enables the entire coagulation system to proceed on a restricted cell surface.

Citing Articles

Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease.

Zisser L, Binder C J Lipid Atheroscler. 2024; 13(3):232-261.

PMID: 39355407 PMC: 11439751. DOI: 10.12997/jla.2024.13.3.232.


Identification of early coagulation changes associated with survival outcomes post severe burns from multiple perspectives.

Huang S, Ma Q, Liao X, Yin X, Shen T, Liu X Sci Rep. 2024; 14(1):10457.

PMID: 38714778 PMC: 11076290. DOI: 10.1038/s41598-024-61194-0.


Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival.

Doubre H, Monnet I, Azarian R, Girard P, Meyer G, Trichereau J Res Pract Thromb Haemost. 2024; 8(2):102359.

PMID: 38666062 PMC: 11043639. DOI: 10.1016/j.rpth.2024.102359.


New insights of platelet endocytosis and its implication for platelet function.

Zhou Y, Dong J, Wang M, Liu Y Front Cardiovasc Med. 2024; 10:1308170.

PMID: 38264257 PMC: 10803655. DOI: 10.3389/fcvm.2023.1308170.


Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism.

Potere N, Abbate A, Kanthi Y, Carrier M, Toldo S, Porreca E JACC Basic Transl Sci. 2023; 8(9):1245-1261.

PMID: 37791298 PMC: 10544095. DOI: 10.1016/j.jacbts.2023.03.017.